Opendata, web and dolomites

ABOPEN

FIRST INSTANT, OFF-THE-LAB AND USER-FRIENDLY BLOOD GROUPING TEST

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ABOPEN project word cloud

Explore the words cloud of the ABOPEN project. It provides you a very rough idea of what is the project "ABOPEN" about.

military    eradicated    months    world    disease    pioneering    personal    company    prevented    rhesus    sold    figo    founding    risk    220    kills    procedure    lab    hemolytic    turnover    sizeable    market    created    stop    influential    blood    federation    37c    instant    pregnant    abopen    limitations       hdfn    rhd    regions    distributors    accuracy    works    millions    international    biologicals    off    transfusions    easily    141    hdnf    roi    profitable    screening    dry    moving    15    trained    setting    million    keeping    immune    despite    device    eldoncards    mothers    2002    similarly    generate    overcoming    danish    network    newborn    precision    laboratory    stored    worldwide    attacks    urgent    deaths    minute    outside    tested    women    format    red    obstretics    customers    majority    44    pregnancy    erase    gynecology    electricity    cells    eldon    24    jobs    performed    mother    affordability    countries    single    2025    children    grouping    tests    babies    fetus    curhe    accidents    hospitals   

Project "ABOPEN" data sheet

The following table provides information about the project.

Coordinator
ELDON BIOLOGICALS A/S 

Organization address
address: SANDTOFTEN 10
city: GENTOFTE
postcode: 2820
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Project website https://www.eldoncard.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ELDON BIOLOGICALS A/S DK (GENTOFTE) coordinator 50˙000.00

Map

 Project objective

Despite being eradicated from the developed world, the Rhesus Disease or HDFN (Hemolytic Disease of the Fetus and Newborn), a disease where the immune system from the mother attacks the red blood cells from their babies, still kills 141,000 children and mothers in developing regions every year. Deaths that could be easily prevented by screening pregnant women for their RhD factor type. Although 15% of RhD(-) women are at risk, 220 million women in developing countries should be tested, since the majority do not know their RhD factor type. At Eldon Biologicals AS (a Danish company created in 2002), we are a profitable company that has already sold millions of EldonCards (a pioneering off-the-lab dry format grouping test) in more than 44 countries and has built a well-established worldwide network of customers and distributors. We are part of the influential International Federation of Gynecology and Obstretics (FIGO) and founding member of CURhE, an international initiative to stop HDNF. Now, we are moving one step further from EldonCards overcoming its limitations to erase HDNF from developing countries. To do so, we have created ABOPEN, a user-friendly off-the-lab grouping test that can be stored for up to 24 months at 37C and works similarly to pregnancy tests, identifying the RhD factor type in just 1 minute and a single-step procedure. ABOPEN can be performed outside a laboratory setting (does not need electricity) by non-trained personnel, while keeping its affordability (it costs just €4), precision and accuracy. ABOPEN has also a sizeable market in developed countries, as an instant and easy to use device to find out about blood grouping for urgent transfusions (accidents, hospitals, military) or just personal information. By end of 2025, we expect to generate €8 million in turnover (ROI of 2.2), while creating 7 new jobs for the company.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ABOPEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ABOPEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

HAC (2019)

ADVANCED TREATMENT OF CONTAMINATED SOIL

Read More  

NAAS (2019)

NaaS - Newsroom as a service

Read More  

Totem Spoon (2019)

Interactive Digital Signage with emotional intelligence for smart cities

Read More